An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat

Proc Natl Acad Sci U S A. 1988 Mar;85(5):1652-6. doi: 10.1073/pnas.85.5.1652.

Abstract

Acquired immunodeficiency syndrome patients are frequently coinfected with Epstein-Barr virus (EBV). In this report, we demonstrate that an EBV immediate-early gene product, BamHI MLF1, stimulates expression of the bacterial chloramphenicol acetyltransferase (CAT) gene linked to the human immunodeficiency virus (HIV) promoter. The HIV promoter sequences necessary for trans-activation by EBV do not include the tat-responsive sequences. In addition, in contrast to the other herpesvirus trans-activators previously studied, the EBV BamHI MLF1 gene product appears to function in part by a posttranscriptional mechanism, since it increases pHIV-CAT protein activity more than it increases HIV-CAT mRNA. This ability of an EBV gene product to activate HIV gene expression may have biologic consequences in persons coinfected with both viruses.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetyltransferases / biosynthesis
  • Chloramphenicol O-Acetyltransferase
  • Cloning, Molecular
  • Gene Expression Regulation
  • Genes, Viral*
  • HIV / genetics*
  • Herpesvirus 4, Human / genetics*
  • Humans
  • Promoter Regions, Genetic
  • Protein Biosynthesis
  • Repetitive Sequences, Nucleic Acid
  • Transcription Factors / genetics*
  • Transcription, Genetic
  • Viral Proteins / genetics*

Substances

  • Transcription Factors
  • Viral Proteins
  • Acetyltransferases
  • Chloramphenicol O-Acetyltransferase